middle.news
Neuren Launches 5% Share Buy-Back Amid Undervaluation Claims
7:02pm on Wednesday 11th of February, 2026 AEDT
•
Pharmaceuticals
Read Story
Neuren Launches 5% Share Buy-Back Amid Undervaluation Claims
7:02pm on Wednesday 11th of February, 2026 AEDT
Key Points
New on-market share buy-back up to 5% of shares over 12 months
Buy-back discretionary and subject to market conditions
Strong cash flow supported by DAYBUE franchise
Ongoing funding for NNZ-2591 clinical development programs
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NEU
OPEN ARTICLE